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constituting 16% of all musculoskeletal system complaints. 2 Various causes of shoulder pain have been described arising from extra and intraarticular structures. Although the most common causes of shoulder pain including local musculoskeletal problems are benign, serious inflammatory, malign and other systemic problems must be considered in a patient presenting with shoulder pain.
Fibrous dysplasia (FD) of bone is a rare disease often associated with severe clinical outcome, including bone pain, deformities, and fractures. 3 FD presents in monostotic form which affects one bone or in polyostotic form which affects several bones. 4 In this article, we present a case of monostotic FD in humeral head which is a rare cause of shoulder pain and review the current literature.
CASE REPORT
A 37-year-old male patient admitted to Physical Medicine and Rehabilitation outpatient clinic due to increased pain at right shoulder for about six months. Patient did not report any trauma to the shoulder area. Although his pain increased with motion, shoulder pain persisted even at rest. Patient had benefited from analgesic medication initially but he stated that his pain increased over time. A written informed consent was obtained from the patient.
On physical examination, his general status was well. Range of motion of the right shoulder joint was minimally limited (flexion and extension in sagittal plane 160° and 40°; abduction and adduction in frontal plane 165° and 50°, respectively). The provocative tests were negative excluding minimally painful shoulder range of motion. 
DISCUSSION
Fibrous dysplasia is an abnormal growth pattern characterized by fibro-osseous replacement of mature marrow with immature abnormal matrix. The abnormal production of fibroconnective tissue is due to a mutation in the GNAS1 gene. 4 Fibrous dysplasia constitutes 2.5% to 7% of benign bone tumors. 5 FD has two subtypes which are polyostotic or monostotic. Polyostotic form has a serious prognosis and frequently affects the craniofacial bones, ribs, and the bones of lower limb. Three percent of FD manifests as McCuneAlbright syndrome with skin pigmentation and hyperfunctioning endocrine disorders. 4, 6 Monostotic FD is more common which affects nearly 70% to 80% of patients with FD. 4 Though the most common involvement site is femoral bone, all bones may be affected.
Pain, fracture, and bone deformity are common clinical features of FD. 7 Of the patients, 67% reported local pain on the involved region. 8 There are some reports about monostotic FD with upper extremity involvement. 9, 10 In one report, prominent shoulder pain and upper extremity deformity have been reported 9 while another case has presented with a deformity of forearm. 10 However, both cases occurred in childhood period. Our patient was older and did not have any deformity. Besides, he presented with nonspecific shoulder pain. He had persisting pain both with motion and at rest. Physical examination of the current case revealed no specific findings other than minimally limited range of motion of shoulder joint.
Radionuclide bone scintigraphy is useful to demonstrate the extent of disease. 7 Also, it is useful for the distinction between monostotic and polyostotic FD. Our case only had a significantly increased isotope uptake on humerus. Computed tomography and magnetic resonance imaging are additional modalities for further elucidating the extent of bony and neurovascular involvement. 11 Bone biopsy is necessary in order to rule out malignancy and useful for preoperative planning. Both magnetic resonance imaging and bone biopsy were performed for the differential diagnosis in the current case.
Malignant transformation of FD occurs in about 0.4% to 4% of the cases. 6 It is more likely to occur in polyostotic disease, in which the transformation is to osteosarcoma, fibrosarcoma, and chondrosarcoma. 7 A study which evaluated the malign transformation of monostotic FD has revealed that the most common histological diagnosis was osteosarcoma. 12 The authors of this study stated that diaphyses of long bones were the primary sites of malignant transformation in monostotic FD. It was also suggested that growth of mass, swelling, and pain might indicate sarcomatosis in patients with monostotic FD. Patients with monostotic FD of humerus had similar symptoms such as pain and swelling. Malign transformation to fibrosarcoma was reported in patients with humerus involvement. One of these patients had a pathologic humerus fracture and both had high pain intensity. 12 Our case only reported nonspecific shoulder pain.
Nevertheless, pain may be the major problem in this group of patients. Although aggressive treatment is not necessary in all patients with monostotic FD, several medications including non-steroidal antiiflammatory drugs and narcotic analgesics have been prescribed for bone pain. Bisphosphonates have also been recommended for pain in order to decrease bone resorption in patients with FD. 3, 13, 14 In general, bisphosphonates have promising results as the initial conservative treatment of FD. Most potent bisphosphonates such as pamidronate and zoledronic acid are preferred for the treatment of these patients. Increased number of osteoclasts and subsequent bone resorption may be seen in FD. Pamidronate, which is a potent inhibitor of osteoclasts, has positive results on pain, normalization of bone turnover, and increased bone density. 4 Furthermore, there are some reports in the literature about the use of low dose alendronate for the treatment of FD and it has been stated that alendronate was effective for decreasing bone pain. [15] [16] [17] The patient in the present study did not have increased bone resorption but had shoulder pain. Therefore, we preferred half dose of weekly alendronate sodium in order to prevent adverse effects. In recent years, some reports have been published about the use of denosumab, a human monoclonal antibody to receptor activator of nuclear factor-kappaB ligand, for the treatment of FD. 18, 19 Although there was significant improvement in pain and bone markers with use of denosumab, authors suggested that physicians should carefully consider biochemical and hormonal changes including hypophosphatemia, secondary hyperparathyroidism, and hypercalcemia. 18, 19 Surgery may be indicated if the patient has major bone deformity or mass compressing the adjacent tissue, causing visual loss or progressive dyspnea. 4, 14 Our case was not referred to surgery because of the normal bone turnover, low fracture risk, lack of other symptoms regarding compression, and good response to medical treatment.
In conclusion, FD may be a rare but important cause of shoulder pain. It should be kept in mind that the physical examination of shoulder does not always rule out a specific shoulder disease. Therefore, careful examination and imaging should be performed particularly in patients with persistent shoulder pain.
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